Dabigatran Etexilate
NDC 67877-624, Dabigatran Etexilate, capsule, coated pellets, from Ascend Laboratories, LLC.
- Product NDC
- 67877-624
- Status
- Listed
- Labeler
- Ascend Laboratories, LLC
- Dosage form
- CAPSULE, COATED PELLETS
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208040
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67877-624 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DABIGATRAN ETEXILATE MESYLATE110 mg/1
Pharmacologic classes
Direct Thrombin Inhibitor [EPC]; Thrombin Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67877-624-31 | 67877062431 | 10 BLISTER PACK in 1 CARTON (67877-624-31) / 6 CAPSULE, COATED PELLETS in 1 BLISTER PACK |
| 67877-624-60 | 67877062460 | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-624-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3a8ec82a-c367-40dc-9302-e1896fcb05eaNADAC price for package 67877062460
GET /v1/drugs/nadac/67877062460
Use it
Look up 67877-624 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67877-624 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67877-624. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.